Skip to content

Biomarkers of organ involvements and severity in idiopathic inflammatory myopathies

Biomarkers of organ involvements and severity in idiopathic inflammatory myopathies - Biomarkers of severity in idiopathic inflammatory myopathies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000051997
Enrollment
250
Registered
2023-08-24
Start date
2023-08-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopathic inflammatory myopathies

Interventions

None listed

Sponsors

Nagasaki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with diagnosed idiopathic inflammatory myopathies between January 2007 and March 2023 at Nagasaki University Hospital

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
The clinical characteristic and biomarkers for distinguishing with organ involvements and severity,and muscle damages in patients with idiopathic inflammatory myopathies.

Countries

Japan

Contacts

Public ContactToshimasa Shimizu

Nagasaki University Hospital Department of Immunology and Rheumatology

tshimizu-ngs@umin.ac.jp095-819-7262

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026